TMBC membership encompasses a broad spectrum of stakeholders from industry, spanning companies working on microbiome based therapeutic modalities, diagnostics, direct-to-consumer products and services and other related constituencies. Membership is open, but not limited, to commercial companies offering an array of products and services including research tools, diagnostic technologies and products, screening services and therapeutic interventions and direct-to-consumer products and services. Membership in TMBC is equally open to universities and academic medical centers, non-profit research entities, relevant trade associations, patient advocacy groups, government officials (ex-officio), health care organizations, health care providers, payers and information technology companies.

See below for a full list of our current members.

Emerging Biotech/Pharmaceutical Companies

     Second Genome

     Whole Biome

Diagnostic Companies

IT/Bioinformatics Companies

     CosmosID

Cosmetics/Therapeutics

     AO Biome

Nutritional Companies

     Abbott Nutrition

Clinical Care Institutions

     Mayo Clinic

esearch Service Providers

     Diversigen

Health Insurance Companies

Strategic Partners